ArticleBiomolecules2026

A Cisplatin-Based Prodrug Inhibits Nucleotide Excision Repair Independently of Chromatin Accessibility to Overcome Resistance.

Ya'ara Negev-Korem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.